STS uses PRT to ensure patient safety
Secure Transfusion Services (STS) is the only commercial blood-collection group that makes 100% use of pathogen-reduction technology (PRT), a system approved by the US Food and Drug Administration (FDA) that minimizes the risk of bacterial and viral contamination in platelet collections.
Our approach eliminates the need for bacterial culture and gamma irradiation and provides specific infectious disease tests and potential protection from emerging pathogens. These vital steps help ensure that STS is a trusted, reliable, and safe source of platelets for hospitals to remain FDA-compliant and deliver lifesaving platelets to the patients they treat.
Read the data that show that PRT reduces pathogens in blood transfusions.
EXPANDED DONOR POOL
Providing enhanced availability and reliability of apheresis platelets from a diverse, younger donor population.
Reducing supply chain interruptions to eliminate the impact to patient care